Thymosin Alpha 1 Mitigates Cytokine Storm in Blood Cells From Coronavirus Disease 2019 Patients.
Open Forum Infect Dis
; 8(1): ofaa588, 2021 Jan.
Article
in English
| MEDLINE | ID: covidwho-1052206
ABSTRACT
BACKGROUND:
Coronavirus disease 2019 (COVID-19) is characterized by immune-mediated lung injury and complex alterations of the immune system, such as lymphopenia and cytokine storm, that have been associated with adverse outcomes underlining a fundamental role of host response in severe acute respiratory syndrome coronavirus 2 infection and the pathogenesis of the disease. Thymosin alpha 1 (Tα1) is one of the molecules used in the management of COVID-19, because it is known to restore the homeostasis of the immune system during infections and cancer.METHODS:
In this study, we captured the interconnected biological processes regulated by Tα1 in CD8+ T cells under inflammatory conditions.RESULTS:
Genes associated with cytokine signaling and production were upregulated in blood cells from patients with COVID-19, and the ex vivo treatment with Tα1-mitigated cytokine expression, and inhibited lymphocyte activation in a CD8+ T-cell subset specifically.CONCLUSION:
These data suggest the potential role of Tα1 in modulating the immune response homeostasis and the cytokine storm in vivo.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Language:
English
Journal:
Open Forum Infect Dis
Year:
2021
Document Type:
Article
Affiliation country:
Ofid
Similar
MEDLINE
...
LILACS
LIS